Your shopping cart is currently empty

NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $195 | In Stock | In Stock | |
| 5 mg | $483 | In Stock | In Stock | |
| 10 mg | $692 | In Stock | In Stock | |
| 25 mg | $1,080 | In Stock | In Stock | |
| 50 mg | $1,490 | In Stock | In Stock | |
| 100 mg | $1,970 | - | In Stock |
| Description | NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia. |
| In vivo | Two structurally distinct NLRP3 inhibitors, NT-0249 and NT-0796, were able to reverse obesity in a mouse model of diet-induced obesity (DIO), and DIO-driven hypothalamic glial fibrillary acidic protein (GFAP) expression could be blocked by administration of NT-0249 or NT-0796. [1] |
| Synonyms | NT0249 |
| Molecular Weight | 481.54 |
| Formula | C22H28N5NaO4S |
| Cas No. | 2763617-39-4 |
| Smiles | [N-](C(NS(N(C[C@@H]1CCCO1)C2=CN(C)N=C2)(=O)=O)=O)C3=C4C(=CC5=C3CCC5)CCC4.[Na+] |
| Relative Density. | no data available |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.